Lilly announces $9 billion investment in Lebanon manufacturing campus to create 900 jobs

The Lebanon City Council meeting on February 10, 2025, highlighted significant developments regarding the expansion of the Eli Lilly manufacturing campus in Lebanon, Indiana. The meeting featured a presentation detailing the progress and future plans for the facility, which is poised to play a crucial role in pharmaceutical manufacturing.

Eli Lilly representatives discussed the ongoing construction of the manufacturing campus, which is part of a $9 billion investment in the area. The campus will include two distinct manufacturing sites, with the first site, referred to as LP 1, being the focus of a request for additional water resources. This site is expected to create over 900 jobs, ranging from frontline operational staff to scientists and engineers.

The presentation emphasized the importance of the manufacturing campus in producing active pharmaceutical ingredients, which are essential for developing new medicines. The construction of additional buildings for small molecule and peptide manufacturing was also noted, with progress on the site advancing rapidly.

In addition to job creation, Eli Lilly is committed to community outreach, having supported over 30 nonprofit organizations and logged more than 2,500 volunteer hours in the past year. The company plans to host career events, starting on March 6 at the Lebanon Fairgrounds, to engage with the community and promote job opportunities.

Overall, the meeting underscored Eli Lilly's dedication to both economic development and community involvement in Lebanon, positioning the city as a key player in the pharmaceutical industry. The council's support for the manufacturing campus is expected to have lasting positive impacts on the local economy and community well-being.